Otsuka of Japan to Buy Avanir Pharmaceuticals for $3.5 Billion by JONATHAN SOBLE

By JONATHAN SOBLE

Otsuka said it would pay $17 a share in cash for Avanir, a developer of treatments for Alzheimer’s, Parkinson’s and other neurological diseases.

Published: December 2, 2014 at 12:00AM

from NYT Business Day http://ift.tt/1vbacSa

from WordPress http://ift.tt/1AbdcCR

via Hadi Aboukhater